Trevi Therapeutics News

Trevi Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Sep 11, 2023 16:05 ET

Trevi Therapeutics | EFFECT: Others

Aug 16, 2023 00:15 ET

Trevi Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Jun 12, 2023 16:47 ET

Trevi Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Apr 11, 2023 11:44 ET

Trevi Therapeutics | 424B5: Prospectus

Sep 23, 2022 17:22 ET

Trevi Therapeutics | 424B5: Prospectus

Sep 22, 2022 16:06 ET

Trevi Therapeutics | 424B5: Prospectus

May 13, 2022 18:27 ET

Trevi Therapeutics | EFFECT: Others

May 12, 2022 00:15 ET

Trevi Therapeutics | EFFECT: Others

Nov 17, 2021 00:15 ET

Trevi Therapeutics | EFFECT: Others

Oct 26, 2021 00:15 ET

Trevi Therapeutics | EFFECT: Others

Jul 15, 2021 00:15 ET

Trevi Therapeutics | 424B3: Prospectus

Jul 14, 2021 17:05 ET

Trevi Therapeutics | EFFECT: Others

Jul 6, 2020 00:15 ET

Trevi Therapeutics | 424B3: Prospectus

Jul 2, 2020 16:26 ET

Trevi Therapeutics | 424B4: Prospectus

May 8, 2019 16:02 ET

Trevi Therapeutics | EFFECT: Others

May 8, 2019 00:16 ET

Trevi Therapeutics | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses

May 7, 2019 13:32 ET

Trevi Therapeutics | 8-A12B: Registration of a class of securities on a national securities exchange

Apr 29, 2019 10:32 ET